Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
发明人:
申请号：
EP14172399.9
公开号：
EP2954896A1
申请日:
2014.06.13
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The present invention relates to Skp2 inhibitors for the use in the therapeutic activation of autophagy and especially for use as an antidepressant. Furthermore the present invention refers to a method of determining if a subject suffering from depression responds to an antidepressant and to a method for screening for novel compounds for the therapeutic activation of autophagy which is suitable for different diseases, such as depression.
